Analyst Ratings for Eli Lilly (LLY)
LLY Rating Summary
LLY Price Target Summary
- Highest: $1,500.00 (Citi)
- Lowest: $835.00 (CFRA)
- Average: $1,233.92
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$1,233.92 (+8.9%)
* Over Last 12-Mos
Rating Score: 7.9 / 10
Percentile Rank: 82%
Rating Score: 7.9 / 10
Percentile Rank: 82%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/17/2026 | HSBC | Rajesh Kumar | Downgrade | Reduce (Hold) |
850.00 (1,070.00) |
985.08 (1133.00) |
15.02% | Details |
| 2/24/2026 | RBC Capital » Updated 5/4/2026 |
Trung Huynh | New Coverage | Outperform (N/A) |
1,250.00 (N/A) |
1058.56 (1133.00) |
7.03% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
